Publications

Affichage de 211 à 220 sur 16198


  • Communication dans un congrès

Sex-specific effects of different diets inducing MAFLD and treatment with the PPARα agonist elafibranor

I. Raho, R. Bertrand, J. Vicogne, A. Abderrahmani, C. Magnan, C. Cruciani-Guglielmacci

Background and aims: Metabolic associated fatty liver disease (MAFLD) is a liver disease characterized by fat accumulation and is often associated with obesity and type 2 diabetes. Recent studies suggest that sex may influence disease progression, although the underlying mechanisms remain unclear.…

61st EASD Annual Meeting of the European Association for the Study of Diabetes, Sep 2025, Vienne, Austria. pp.id 580, ⟨10.1007/s00125-025-06497-1⟩. ⟨hal-05508997⟩